4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-069018
Director acquired 2,057 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PATOU GARY Director | 2021-12-08 | Option exercise | +2,057 | $3.67 | $7,549 | 25,630 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| PATOU GARY Director | 2021-12-08 | Option exercise · Stock Option (Right to Buy) | −2,057 | 0 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…